In the past few years we have seen price hikes of pharmaceutical drugs — the most well-known incident is of the drug Daraprim, which jumped from $13.50 to $750 per pill after being purchased by the infamous entrepreneur and pharmaceutical executive Martin Shkreli.
It is extremely important for the health and well being of the nation that we choose leaders who will help regulate Big Pharma better to prevent future prescription drug deaths, to revamp the system to allow for more independent, long-term safety testing as well as keep the industry in check so that they don’t shake down the consumer financially even more than they already have.
Donations by the pharmaceutical industry to the presidential candidates may give us a few important clues as to how things may play out.
The Center for Responsive Politics has released the numbers of monetary contributions to each presidential candidate as of January 31, 2016, sorted by the industry.
When it comes to Pharmaceuticals and Health Products, Hillary Clinton received about a third of all donations: a whopping $336,416.
She is followed by Jeb Bush and Marco Rubio with $152,350 and $133,638 in donations. Bernie Sanders received $44,242 and Donald Trump – $1,010.
In total the industry has donated $951,018 to the 2016 elections so far, out of which $41.4% went to Democrats, and 58.6% to Republicans.
When it comes to other health related industries, Health Services/HMOs donated $382,832 to Clinton, $133,600 to Bush, and $42,462 to Sanders.
The pharmaceutical industry is the 15th biggest source of political donations right now, and the health industry as a whole (including health services, health professionals, and hospitals) is the 3rd biggest donator with over $9.5 million in contributions. Clinton received more than $3.5 million, more than one third of the total donations.
“Established industries and lobbies give primarily to establishment candidates that they perceive will be leaders and eventual nominees,” according to Scott Swenson, vice president for communications for a nonprofit political watchdog group Common Cause, reported CNN.
It looks as though Big Pharma has placed their bets on a Hillary Clinton presidency (much like Monsanto and the GMO industry have) and that they’ll do just about everything they can to make sure she’s putting their interests first when it comes time to make the big decisions (should she end up winning the nomination, that is).